World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
79
Citations
37035
World Ranking
1658
National Ranking
820

Lawrence Fong publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Lawrence Fong sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 358 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Lawrence Fong D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Lawrence Fong sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 79 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Lawrence Fong is affiliated with the University of California, San Francisco in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a significant focus on Oncology and Immunology among the subfields of study.

Their scholarly output covers a range of topics related to cancer and immunotherapy. Major themes in their work include:

  • Cancer Immunotherapy and Biomarkers
  • Prostate Cancer Treatment and Research
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Radiopharmaceutical Chemistry and Applications
  • Bladder and Urothelial Cancer Treatments
  • Immune Cell Function and Interaction

Several frequent co-authors have collaborated extensively with Fong, including:

  • Li Zhang
  • Rahul Aggarwal
  • Terence W. Friedlander
  • Eric J. Small
  • David Y. Oh

Their work has been published in multiple peer-reviewed venues, with notable frequency in:

  • Journal of Clinical Oncology
  • Regular and Young Investigator Award Abstracts
  • Cancer Research
  • Journal for ImmunoTherapy of Cancer
  • Cancer Immunology Research

Representative recent publications include:

  • "Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer," 2020, Cell
  • "Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus," 2022, Science
  • "Tissue Determinants of Human NK Cell Development, Function, and Residence," 2020, Cell
  • "Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox," 2021, Immunity
  • "Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes," 2023, Cell

Best Publications

  • TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

    Sanjeev Mariathasan;Shannon J. Turley;Dorothee Nickles;Alessandra Castiglioni

  • Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.

    Peter P. Lee;Cassian Yee;Peter A. Savage;Lawrence Fong

  • Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory

    Mauro Poggio;Tianyi Hu;Chien Chun Pai;Brandon Chu

  • Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

    Lawrence Fong;Yafei Hou;Alberto Rivas;Claudia Benike

  • Dendritic Cells in Cancer Immunotherapy

    Lawrence Fong;Edgar G. Engleman

  • Systemic Immunity Is Required for Effective Cancer Immunotherapy

    Matthew H. Spitzer;Yaron Carmi;Yaron Carmi;Nathan E. Reticker-Flynn;Serena S. Kwek

  • Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer.

    David Y. Oh;Serena S. Kwek;Siddharth S. Raju;Tony Li

  • Single-cell RNA-seq reveals cell type–specific molecular and genetic associations to lupus

    Unknown

  • Dendritic Cells Injected Via Different Routes Induce Immunity in Cancer Patients

    Lawrence Fong;Dirk Brockstedt;Claudia Benike;Lijun Wu

  • A Pilot Trial of CTLA-4 Blockade with Human Anti-CTLA-4 in Patients with Hormone-Refractory Prostate Cancer

    Eric J. Small;N. Simon Tchekmedyian;Brian I. Rini;Lawrence Fong

  • Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patients.

    Edward Cha;Mark Klinger;Yafei Hou;Craig Cummings

  • Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox

    Unknown

  • Tissue Determinants of Human NK Cell Development, Function, and Residence

    Pranay Dogra;Chiara Rancan;Wenji Ma;Marta Toth

  • Anti–Cytotoxic T-Lymphocyte Antigen-4 Antibody: The First in an Emerging Class of Immunomodulatory Antibodies for Cancer Treatment

    Lawrence Fong;Eric J. Small

  • Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy

    Lawrence Fong;Dirk Brockstedt;Claudia Benike;Jami K. Breen

  • Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes

    Unknown

  • Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer

    Ki Y. Chung;Ira Gore;Lawrence Fong;Alan Venook

  • A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer.

    Eric J. Small;Michael A. Carducci;James M. Burke;Ron Rodriguez

  • Spontaneous autoimmunity prevented by thymic expression of a single self-antigen

    Jason DeVoss;Yafei Hou;Kellsey Johannes;Wen Lu

  • CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion

    Brian Kavanagh;Shaun O'Brien;David Lee;Yafei Hou

  • Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma.

    Toni K. Choueiri;Mayer Fishman;Bernard Escudier;David F. McDermott

  • Potentiating Endogenous Antitumor Immunity to Prostate Cancer through Combination Immunotherapy with CTLA4 Blockade and GM-CSF

    Lawrence Fong;Serena S. Kwek;Shaun O'Brien;Brian Kavanagh

  • Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide.

    D T Kim;D J Mitchell;D G Brockstedt;L Fong

Frequent Co-Authors

Eric J. Small
Eric J. Small University of California, San Francisco
Toni K. Choueiri
Toni K. Choueiri Harvard University
David I. Quinn
David I. Quinn University of Southern California
Joaquim Bellmunt
Joaquim Bellmunt Beth Israel Deaconess Medical Center
Cora N. Sternberg
Cora N. Sternberg Cornell University
Brian I. Rini
Brian I. Rini Vanderbilt University Medical Center
Dean F. Bajorin
Dean F. Bajorin Memorial Sloan Kettering Cancer Center
David F. McDermott
David F. McDermott Beth Israel Deaconess Medical Center
Bernard Escudier
Bernard Escudier Institut Gustave Roussy
Winald R. Gerritsen
Winald R. Gerritsen Radboud University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Immunology opens up diverse career opportunities in healthcare and research. For those interested in patient care and clinical roles, pursuing nursing degrees related to immunology and public health can be a strategic choice. Many students seek programs with accessible admissions, such as easy admission lpn programs, which provide a solid foundation for entry into nursing careers.

For advanced practice nurses, online options present flexible pathways. The easiest nurse practitioner degree programs offer streamlined admission processes while still preparing students for vital roles in healthcare. Specializing further, many students consider mental health, where programs focusing on psychiatric care are in high demand.

Notably, the best psychiatric mental health nurse practitioner programs online ensure strong clinical placement rates, crucial for hands-on experience. Additionally, for budget-conscious students, identifying affordable pmhnp programs can make advanced psychiatric nursing education more accessible.

Overall, combining immunology knowledge with nursing credentials enhances career flexibility, allowing professionals to impact patient care, research, and public health initiatives effectively.

Best Scientists Citing Lawrence Fong

Trending Scientists

Recently Published Articles